FDA Steps Up Focus On Computational Modeling For Devices With Draft Guidance
Executive Summary
The draft guidance outlines information on computational and simulation modeling studies that should be included in FDA device submissions. FDA has been encouraging companies to focus on modeling studies with a goal that they could eventually replace costly bench and animal studies.